Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
-
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
-
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
-
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
-
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
-
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
-
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
-
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
-
Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
-
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania